Inovio Pharmaceuticals
INO
INO
208 hedge funds and large institutions have $428M invested in Inovio Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 62 increasing their positions, 63 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
15% less call options, than puts
Call options by funds: $15.5M | Put options by funds: $18.2M
23% less capital invested
Capital invested by funds: $555M → $428M (-$126M)
Holders
208
Holding in Top 10
–
Calls
$15.5M
Puts
$18.2M
Top Buyers
| 1 | +$11.7M | |
| 2 | +$10.9M | |
| 3 | +$6.68M | |
| 4 |
Rafferty Asset Management
New York
|
+$2.41M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.27M |
Top Sellers
| 1 | -$1.85M | |
| 2 | -$1.55M | |
| 3 | -$1.14M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$1.08M |
| 5 |
Morgan Stanley
New York
|
-$1.06M |